Sign In
Buy ELOX
$12.05
+0.300 (+2.55%)
At Close: Jun 26, 2026
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
92 Biggest Movers From Yesterday
09:41am, Thursday, 05'th Mar 2020
Gainers
Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 45% to close at $3.03 on Wednesday. Cellect Biotechnology and Canndoc Ltd. agreed to enter into strategic pharma...
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLa
Zacks: Senesco Technologies Inc. (NYSE:ELOX) Given $13.75 Average Target Price by Analysts
10:04am, Friday, 28'th Feb 2020
Senesco Technologies Inc. (NYSE:ELOX) has been given an average broker rating score of 1.50 (Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. One equi
Eloxx Strengthens its Commitment to Cystic Fibrosis Through Reallocating Resources
09:00pm, Wednesday, 26'th Feb 2020
Eloxx Pharmaceuticals, Inc. (ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by no
Eloxx Pharma down 30% on underwhelming data on lead candidate
08:49pm, Tuesday, 14'th Jan 2020
Thinly traded micro cap Eloxx Pharmaceuticals (ELOX -29.6%) slumps on 82% higher volume, a modest 527K shares, on the heels of its update on lead drug ELX-02, a eukaryotic ribosomal selective glycosid
Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase™
07:30pm, Tuesday, 14'th Jan 2020
Eloxx Pharmaceuticals, Inc. (ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis, inherited retinal
Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase™
07:30pm, Tuesday, 14'th Jan 2020
Phase 2 cystic fibrosis program for ELX-02 expected to be fully enrolled in the first quarter of 2020 and topline results expected during the first half of...
Will Eloxx Continue to Surge Higher?
11:38am, Friday, 27'th Dec 2019
As of late, it has definitely been a great time to be an investor in Eloxx.
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX): What Does Its Beta Value Mean For Your Portfolio?
12:45pm, Tuesday, 24'th Dec 2019
Anyone researching Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) might want to consider the historical volatility of the...
Hedge Funds Have Never Been This Bullish On Eloxx Pharmaceuticals, Inc. (ELOX)
11:41pm, Sunday, 22'nd Dec 2019
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before last year's Q4 market crash that the stock market is overvalued due to a low interest rate environment that le
Eloxx Pharmaceuticals to Present at the Biotech Showcase™ 2020 on January 14, 2020
12:00pm, Wednesday, 18'th Dec 2019
Eloxx Pharmaceuticals, Inc. (ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis, inherited retinal
Edited Transcript of ELOX earnings conference call or presentation 5-Nov-19 9:30pm GMT
10:09pm, Wednesday, 11'th Dec 2019
Q3 2019 Eloxx Pharmaceuticals Inc Earnings Call
Eloxx Pharmaceuticals, Inc. (ELOX) Shares March Higher, Can It Continue?
12:43pm, Friday, 06'th Dec 2019
As of late, it has definitely been a great time to be an investor in Eloxx Pharmaceuticals, Inc. (ELOX).
Eloxx Pharmaceuticals to Present at the Evercore ISI 2nd Annual HealthCONx on December 4th, 2019
12:00pm, Tuesday, 19'th Nov 2019
Eloxx Pharmaceuticals, Inc. (ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis, inherited retinal
